Rebalix
Logo UBSUBS · sheet of 10 September 2026
ETF sheet · official issuer and register data

UBS MSCI Europe Socially Responsible UCITS ETF EUR acc

LU2206597804 · LU2206597804 · EUR · domicile Luxembourg
Equity · Europe · Sustainable / ESGSFDR art. 8
Index tracked: MSCI Europe SRI Low Carbon Select 5% Issuer Capped Total Return Net
TER
0.18%+ trans. 0.02%
Fund size
61 m EUR
Tracking difference
+0.14%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 26 Feb 2021 · costs from the KID as of 2 Sept 2026 · 0 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the MSCI Europe SRI Low Carbon Select 5% Issuer Capped Index (Net Return) either through direct investments in all or substantially all of the component securities and/or through the use of derivatives in particular where it may not be possible or practicable to replicate the index through direct investments or in order to generate efficiencies in gaining exposure to the index. The Index is designed to measure the performance of best-in-class Environmental, Social and…

Performance since series start (in euro) — base 100

26 Feb 20218 Sept 2026 · dividends reinvested where declared by the issuer
2022202320242025202617298168
High 172 (7 Aug 2026) · low 98 (29 Sept 2022) · last 168. Past performance is not indicative of future results.

Returns in euro

1 year+16.9%
3 years+40.5%
5 years+37.2%
10 yearsseries too young
Since series start+68.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.46%12.41%14.07%
Max drawdown−10.41%−16.03%−22.88%
Sharpe1.080.710.35
Sortino1.651.000.49
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU2206597804 · LU22065978041
RebalixLU2206597804 · LU2206597804 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+6.22%+6.06%+0.16%
2024+11.84%+11.70%+0.13%
2023+18.01%+17.86%+0.14%
2022−13.71%−13.90%+0.20%

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 41.3%
Top holdingsWeight
ASML Holding NV5.4%
Schneider Electric SE5.3%
Roche Holding AG5.0%
Novartis AG4.9%
SAP SE4.7%
ABB Ltd4.6%
Zurich Insurance Group AG3.5%
ING Groep NV3.2%
AXA SA2.5%
Industria de Diseno Textil SA2.2%
Countries (% of fund)
Svizzera26.7%Regno Unito14.6%Paesi Bassi14.4%Francia14.2%Germania10.2%
Sectors (% of fund)
Finanza27.7%Industria21.7%Salute15.1%Informatica10.2%Beni di consumo7.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
EURSRI · Borsa Italiana (ETFplus)
UIW1 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ubs.com/2/e/priip/PRIIPSEU_LU2206597804_en_IE.pdf
Factsheet · www.ubs.com/2/e/files/RET/FS_RET_LU2206597804_IT_IT.pdf
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU2206597804
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU2206597804 · LU22065978042